Burning Rock Biotech Ltd(BNR)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2025-12-31.

Burning Rock Biotech Ltd (BNR) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores BNR at 27.4/100 on a 32-signal composite quality model, placing it at rank #2,583 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), Burning Rock Biotech Ltd reports quarterly revenue of $77.2M, net income of $-7.9M, an operating margin of -10.2%. Top institutional holders of BNR by reported 13-F value include Kynam Capital Management, CRCM, RENAISSANCE TECHNOLOGIES, based on the most recent SEC filings. BNR trades on the Nasdaq exchange and files with the SEC under CIK 1792267. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BNR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Burning Rock Biotech Ltd directly from SEC EDGAR.